Related Experiment Video
Updated: Aug 23, 2026
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer
Pia Huusko1, Damaris Ponciano-Jackson, Maija Wolf
1Translational Genomics Research Institute, Cancer Drug Development Laboratory, 20 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878, USA.
Abstract:
The identification of tumor-suppressor genes in solid tumors by classical cancer genetics methods is difficult and slow. We combined nonsense-mediated RNA decay microarrays and array-based comparative genomic hybridization for the genome-wide identification of genes with biallelic inactivation involving nonsense mutations and loss of the wild-type allele. This approach enabled us to identify previously unknown mutations in the receptor tyrosine kinase gene EPHB2. The DU 145 prostate cancer cell line, originating from a brain metastasis, carries a truncating mutation of EPHB2 and a deletion of the remaining allele. Additional frameshift, splice site, missense and nonsense mutations are present in clinical prostate cancer samples. Transfection of DU 145 cells, which lack functional EphB2, with wild-type EPHB2 suppresses clonogenic growth. Taken together with studies indicating that EphB2 may have an essential role in cell migration and maintenance of normal tissue architecture, our findings suggest that mutational inactivation of EPHB2 may be important in the progression and metastasis of prostate cancer.
Insights
Researchers identified inactivating mutations in the EPHB2 gene, a potential tumor suppressor, in prostate cancer. This discovery offers new insights into cancer progression and metastasis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Identifying tumor-suppressor genes in solid tumors is challenging with traditional methods.
- Nonsense-mediated RNA decay (NMD) and array-based comparative genomic hybridization (aCGH) offer advanced approaches.
Purpose of the Study:
- To develop and apply a genome-wide strategy for identifying genes with biallelic inactivation.
- To investigate the role of the EPHB2 gene in prostate cancer progression and metastasis.
Main Methods:
- Combined nonsense-mediated RNA decay microarrays and array-based comparative genomic hybridization.
- Analyzed mutations in the EPHB2 gene in prostate cancer cell lines and clinical samples.
Main Results:
- Identified previously unknown mutations in the EPHB2 receptor tyrosine kinase gene.
- The DU 145 prostate cancer cell line harbors a truncating EPHB2 mutation and allele deletion.
- Found various EPHB2 mutations (frameshift, splice site, missense, nonsense) in clinical prostate cancer samples.
- Restoring functional EphB2 in DU 145 cells suppressed clonogenic growth.
Conclusions:
- Mutational inactivation of EPHB2 is implicated in prostate cancer progression and metastasis.
- EphB2 plays a critical role in cell migration and maintaining normal tissue architecture.
- The developed genome-wide approach is effective for identifying tumor suppressor genes.
Related Concept Videos
02:27Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
02:27Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
02:23Abnormal Proliferation
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:36Mismatch Repair